Xvivo Perfusion Q3’20: First impression
Research Note
2020-10-23
08:11
Redeyes first impressions on the Q3 results. Sales came in slightly higher than we expected at SEK 42.7m vs. our SEK 40.2m. The gross margin was a tad higher than expected at 78% vs. our expectation of 76.5%. There are relatively small deviations considering the low visibility at present.
MH
Mats Hyttinge
Disclosures and disclaimers